Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2011-05-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta15suppl1/07 |